Jean-Michel Dogné

University of Namur — Belgium

Medicine · Health Sciences

25h-index1.8kcitations62works7.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Atrial Fibrillation Management and Outcomes(13), SARS-CoV-2 and COVID-19 Research(11), Venous Thromboembolism Diagnosis and Management(9), COVID-19 Clinical Research Studies(8), Cardiac Arrhythmias and Treatments(7)

Publications62 total

Hydroxychloroquine use during the first COVID-19 wave: a case study highlighting the urgent need to enhance research practices within the publication ecosystem
Archives of Public Health·2025· 1 citedOpen Access
Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis
Frontiers in Endocrinology·2024· 33 citedOpen Access
Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update
Clinical Chemistry and Laboratory Medicine (CCLM)·2024· 7 citedOpen Access
Vaccine‐induced humoral response of BNT162b2 and mRNA-1273 against BA.1, BA.5, and XBB.1.5. (sub)variants 6 months after a homologous booster: is immunogenicity equivalent?
Heliyon·2024· 1 citedOpen Access
Vaccine‐Induced Humoral Response of BNT162b2 and MRNA-1273 Against BA.1, BA.5, and XBB.1.5. (Sub)Variants 6 Months after a Homologous Booster: Is Immunogenicity Equivalent?
SSRN Electronic Journal·2024Open Access
Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS‐CoV‐2 Variants: A Case Report Study with Comparison to a Vaccinated Population
Case Reports in Infectious Diseases·2024Open Access
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone
The Journal of Clinical Endocrinology & Metabolism·2022· 33 citedOpen Access
Identification of SARS-CoV-2 Neutralizing Antibody with Pseudotyped Virus-based Test on HEK-293T hACE2 Cells
BIO-PROTOCOL·2022· 11 citedOpen Access
Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers
Vaccines·2021· 128 citedOpen Access
Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2
Microorganisms·2021· 42 citedOpen Access
Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)
Clinical Microbiology and Infection·2021· 71 citedOpen Access
Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients
Clinical Chemistry and Laboratory Medicine (CCLM)·2020· 18 citedOpen Access
Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study
Thrombosis Research·2020· 41 citedOpen Access
Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?
Annales de biologie clinique·2020· 1 citedOpen Access
High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies
Clinical Biochemistry·2020· 26 citedOpen Access
The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study
Frontiers in Pharmacology·2020· 31 citedOpen Access
Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies
Clinical Chemistry·2020· 113 citedOpen Access
The role of serology for COVID-19 control: Population, kinetics and test performance do matter
Journal of Infection·2020· 28 citedOpen Access
PS1188 AN UPDATED META‐ANALYSIS OF THE RISKS OF ARTERIAL AND VENOUS OCCLUSIVE EVENTS WITH NEW GENERATION BCR‐ABL TKIS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
HemaSphere·2019Open Access
PF246 PERSONALIZED FOLLOW‐UP OF ACUTE MYELOID LEUKEMIA THROUGH MULTIPARAMETER FLOW CYTOMETRY: A PROOF OF CONCEPT
HemaSphere·2019Open Access
page 1 of 4Next →

Frequent Co-authors

Jonathan Douxfils(29), François Mullier(20), Julien Favresse(10), Julie Laloy(10), Bernard Châtelain(9), Marc Elsen(7), Constant Gillot(6), Stéphane Lucas(6), Bernard Pirotte(6), Sarah Lessire(5), Jean‐Louis Bayart(5), Clara David(5), Christine Eucher(5), Mélanie Closset(5), Marie Tré‐Hardy(5), Lütfiye Alpan(5), Sandrine Van Eeckhoudt(3), Paul Hjemdahl(3), C Chatelain(3), Valentine Minet(3)